OMX Copenhagen 20

OMX Copenhagen 20 handeln
1.544,40 PKT +5,93 PKT +0,39 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN A0AEM7


Analysen zu OMX Copenhagen 20-Werten

Datum Rating Analyst
23.02.26 Novo Nordisk Equal Weight Barclays Capital
23.02.26 Novo Nordisk Hold Jefferies & Company Inc.
23.02.26 Novo Nordisk Equal Weight Barclays Capital
23.02.26 Novo Nordisk Neutral UBS AG
23.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
23.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
23.02.26 Novo Nordisk Buy Goldman Sachs Group Inc.
19.02.26 Novo Nordisk Equal Weight Barclays Capital
18.02.26 Novo Nordisk Equal Weight Barclays Capital
17.02.26 Novo Nordisk Equal Weight Barclays Capital
13.02.26 Novo Nordisk Equal Weight Barclays Capital
12.02.26 Novo Nordisk Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
12.02.26 Novo Nordisk Hold Jefferies & Company Inc.
11.02.26 Novo Nordisk Buy Deutsche Bank AG
10.02.26 Novo Nordisk Equal Weight Barclays Capital
09.02.26 Novo Nordisk Equal Weight Barclays Capital
06.02.26 Novo Nordisk Neutral UBS AG
06.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
06.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
05.02.26 Novo Nordisk Buy Deutsche Bank AG
05.02.26 Novo Nordisk Neutral UBS AG
04.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
03.02.26 Novo Nordisk Underperform Jefferies & Company Inc.
03.02.26 Novo Nordisk Equal Weight Barclays Capital
02.02.26 Novo Nordisk Overweight JP Morgan Chase & Co.
02.02.26 Novo Nordisk Neutral UBS AG
30.01.26 Novo Nordisk Overweight JP Morgan Chase & Co.
23.01.26 Novo Nordisk Underperform Jefferies & Company Inc.
23.01.26 Novo Nordisk Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
22.01.26 A.P. Moeller - Maersk A-S (B) Underweight JP Morgan Chase & Co.
22.01.26 Novo Nordisk Buy Goldman Sachs Group Inc.
22.01.26 Novo Nordisk Equal Weight Barclays Capital
21.01.26 Novo Nordisk Neutral UBS AG
21.01.26 Novo Nordisk Underperform Jefferies & Company Inc.
20.01.26 Novo Nordisk Neutral UBS AG
16.01.26 Novo Nordisk Buy Deutsche Bank AG
16.01.26 Novo Nordisk Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
15.01.26 Novo Nordisk Equal Weight Barclays Capital
15.01.26 Novo Nordisk Neutral UBS AG
15.01.26 Novo Nordisk Overweight JP Morgan Chase & Co.